Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (979)
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
2,907
Price
$311.80
Total Value
$906.39K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
6,273
Price
$310.75
Total Value
$1.95M
Shares Held After
2,907
% of Holdings
68.3%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
5,146
Price
$310.08
Total Value
$1.60M
Shares Held After
9,180
% of Holdings
35.9%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
2,915
Price
$31.71
Total Value
$92.43K
Shares Held After
24,353
% of Holdings
10.7%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
31,885
Price
$31.05
Total Value
$990.03K
Shares Held After
27,268
% of Holdings
53.9%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
70,200
Price
$29.96
Total Value
$2.10M
Shares Held After
59,153
% of Holdings
54.3%
Sagimet Biosciences Inc. (SGMT)
Kemble George — Director
Shares
18,844
Price
$7.46
Total Value
$140.53K
Shares Held After
62,161
% of Holdings
23.3%
Sagimet Biosciences Inc. (SGMT)
Rozek Elizabeth — Chief Legal&Admin. Officer
Shares
10,545
Price
$7.76
Total Value
$81.83K
Shares Held After
224,414
% of Holdings
4.5%
Sagimet Biosciences Inc. (SGMT)
Happel David — Director
Shares
64,051
Price
$7.76
Total Value
$497.07K
Shares Held After
741,570
% of Holdings
8.0%
Aktis Oncology, Inc. (AKTS)
Herrmann Ken — Director
Shares
1,350
Price
$24.56
Total Value
$33.16K
Shares Held After
0
% of Holdings
100.0%
Aktis Oncology, Inc. (AKTS)
Herrmann Ken — Director
Shares
3,506
Price
$24.56
Total Value
$86.12K
Shares Held After
1,350
% of Holdings
72.2%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
1,623
Price
$2.44
Total Value
$3.96K
Shares Held After
2,855,960
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$536.41
Total Value
$42.91K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$535.20
Total Value
$278.31K
Shares Held After
324,523
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
889
Price
$534.13
Total Value
$474.84K
Shares Held After
325,043
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,686
Price
$533.03
Total Value
$898.68K
Shares Held After
325,932
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,874
Price
$532.07
Total Value
$997.10K
Shares Held After
327,618
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,660
Price
$531.08
Total Value
$881.59K
Shares Held After
329,492
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
960
Price
$529.85
Total Value
$508.66K
Shares Held After
331,152
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,831
Price
$529.19
Total Value
$968.94K
Shares Held After
332,112
% of Holdings
0.5%
Imunon, Inc. (IMNN)
Eylward Susan — General Counsel and Corp Sec
Shares
2,150
Price
$1.78
Total Value
$3.83K
Shares Held After
2,896
% of Holdings
42.6%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
5,000
Price
$3.46
Total Value
$17.30K
Shares Held After
640,812
% of Holdings
0.8%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
280
Price
$555.05
Total Value
$155.41K
Shares Held After
209,329
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
1
Price
$550.72
Total Value
$550.72
Shares Held After
209,609
% of Holdings
0.0%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
153
Price
$550.01
Total Value
$84.15K
Shares Held After
209,610
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
47
Price
$548.87
Total Value
$25.80K
Shares Held After
209,763
% of Holdings
0.0%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
680
Price
$547.70
Total Value
$372.43K
Shares Held After
209,810
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
269
Price
$547.08
Total Value
$147.16K
Shares Held After
210,490
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
275
Price
$545.71
Total Value
$150.07K
Shares Held After
210,759
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
545
Price
$544.71
Total Value
$296.87K
Shares Held After
211,034
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
110
Price
$543.79
Total Value
$59.82K
Shares Held After
211,579
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
140
Price
$542.75
Total Value
$75.98K
Shares Held After
211,689
% of Holdings
0.1%
Anixa Biosciences Inc (ANIX)
Titterton Lewis H jr — Director
Shares
12,000
Price
$3.47
Total Value
$41.64K
Shares Held After
986,967
% of Holdings
1.2%
Greenland Mines Ltd (GRML)
McGarity Jon — Director
Shares
140,000
Price
$0.18
Total Value
$24.82K
Shares Held After
551,277
% of Holdings
25.4%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
265
Price
$2.44
Total Value
$646.60
Shares Held After
2,854,337
% of Holdings
0.0%
Rani Therapeutics Holdings, Inc. (RANI)
Imran Talat — Director
Shares
35,000
Price
$0.72
Total Value
$25.19K
Shares Held After
469,736
% of Holdings
7.5%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
63
Price
$53.92
Total Value
$3.40K
Shares Held After
25,000
% of Holdings
0.3%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
2,184
Price
$53.42
Total Value
$116.67K
Shares Held After
25,063
% of Holdings
8.0%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
2,063
Price
$52.39
Total Value
$108.08K
Shares Held After
27,247
% of Holdings
7.0%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
459
Price
$51.55
Total Value
$23.66K
Shares Held After
29,310
% of Holdings
1.5%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
231
Price
$50.05
Total Value
$11.56K
Shares Held After
29,769
% of Holdings
0.8%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
123
Price
$53.87
Total Value
$6.63K
Shares Held After
46,054
% of Holdings
0.3%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
2,638
Price
$53.38
Total Value
$140.82K
Shares Held After
46,177
% of Holdings
5.4%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
2,564
Price
$52.32
Total Value
$134.14K
Shares Held After
48,815
% of Holdings
5.0%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
369
Price
$51.48
Total Value
$19.00K
Shares Held After
51,379
% of Holdings
0.7%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
324
Price
$49.97
Total Value
$16.19K
Shares Held After
51,748
% of Holdings
0.6%
ProQR Therapeutics N.V. (PRQR)
Filius Bart — Director
Shares
150,000
Price
$1.72
Total Value
$257.93K
Shares Held After
300,000
% of Holdings
50.0%
ImageneBio, Inc. (IMA)
Lally Robert B — Principal Accounting Officer
Shares
1,525
Price
$5.34
Total Value
$8.14K
Shares Held After
55,582
% of Holdings
2.7%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
416
Price
$26.53
Total Value
$11.04K
Shares Held After
51,384
% of Holdings
0.8%
Fulcrum Therapeutics, Inc. (FULC)
TANG KEVIN — 10% Owner
Shares
50,945
Price
$3.52
Total Value
$179.33K
Shares Held After
7,080,945
% of Holdings
0.7%
Showing 151–200 of 979 transactions (page 4 of 20)